Romiplostim

Romiplostim · Fc fusion protein TPO receptor agonist

Long-term treatment of chronic immune thrombocytopenia in adults to raise platelet counts

Multiple strengths Weekly subcutaneous injection Individualized dosing

Therapeutic Areas

Hematology

Marketed Products

Romiplostim

Modality

Romiplostim

Core Products

Imatinib · BCR-ABL tyrosine kinase inhibitor

Rivaroxaban · Oral factor Xa inhibitor

Eltrombopag · Thrombopoietin receptor agonist

Creating a Healthier Future Together

Explore our innovative products and pipeline, and see how Poseidon brings hope to patients worldwide